• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从凝血因子VIII浓缩物中恢复和灭活传染性逆转录病毒。

Recovery and inactivation of infectious retroviruses from factor VIII concentration.

作者信息

Levy J A, Mitra G, Mozen M M

出版信息

Lancet. 1984 Sep 29;2(8405):722-3. doi: 10.1016/s0140-6736(84)92627-8.

DOI:10.1016/s0140-6736(84)92627-8
PMID:6148474
Abstract

The ability of infectious retroviruses to withstand the procedures used for factor VIII concentration was investigated. Mouse retroviruses added to human plasma survived these procedures and remained infectious in lyophilised samples of factor VIII. Lyophilised material had to be heated at 68 degrees C for several hours before substantial quantities of infectious virus became inactivated. These findings support the possible role of retroviruses in AIDS, and indicate that factor VIII concentrates must be heated to inactivate these infectious viruses.

摘要

研究了传染性逆转录病毒耐受用于浓缩凝血因子VIII的程序的能力。添加到人类血浆中的小鼠逆转录病毒在这些程序中存活下来,并在凝血因子VIII的冻干样本中保持感染性。冻干材料必须在68摄氏度下加热数小时,大量感染性病毒才会失活。这些发现支持了逆转录病毒在艾滋病中可能发挥的作用,并表明凝血因子VIII浓缩物必须加热以灭活这些感染性病毒。

相似文献

1
Recovery and inactivation of infectious retroviruses from factor VIII concentration.从凝血因子VIII浓缩物中恢复和灭活传染性逆转录病毒。
Lancet. 1984 Sep 29;2(8405):722-3. doi: 10.1016/s0140-6736(84)92627-8.
2
Inactivation of retroviruses in biologicals manufactured for human use.
Dev Biol Stand. 1991;75:159-69.
3
Evaluation of two viral inactivation methods for the preparation of safer factor VIII and factor IX concentrates.
Transfusion. 1985 Nov-Dec;25(6):510-5. doi: 10.1046/j.1537-2995.1985.25686071421.x.
4
Safety of human blood products: inactivation of retroviruses by heat treatment at 60 degrees C.
Proc Soc Exp Biol Med. 1985 Apr;178(4):580-4. doi: 10.3181/00379727-178-42045.
5
Preliminary clinical experience: pharmacokinetics and tolerance of a double-virus-inactivated factor VIII preparation.初步临床经验:双病毒灭活因子VIII制剂的药代动力学和耐受性
Blood Coagul Fibrinolysis. 1995 Jul;6 Suppl 2:S84-5.
6
Antibody to hepatitis C virus after a vapour-heated factor VIII concentrate. The Study Group of the Fondazione dell'Emofilia.
Thromb Haemost. 1990 Oct 22;64(2):232-4.
7
[Factor VIII:C activity during heat inactivation of viruses in cryoprecipitates].[冷沉淀中病毒热灭活过程中的凝血因子 VIII:C 活性]
Lijec Vjesn. 1990 Jul-Aug;112(7-8):212-5.
8
Dry-heat treatment process for enhancing viral safety of an antihemophilic factor VIII concentrate prepared from human plasma.用于提高从人血浆制备的抗血友病因子VIII浓缩物病毒安全性的干热治疗工艺。
J Microbiol Biotechnol. 2008 May;18(5):997-1003.
9
[Anti-hemophilia drugs: from cryoprecipitate to factor VIII concentrates of high purity].
Ukr Biokhim Zh (1978). 1995 Jan-Feb;67(1):3-13.
10
Viral safety of plasma-derived factor VIII and IX concentrates.
Blood Coagul Fibrinolysis. 1997 Aug;8 Suppl 1:S19-23.

引用本文的文献

1
Pathogenesis of human immunodeficiency virus infection.人类免疫缺陷病毒感染的发病机制
Microbiol Rev. 1993 Mar;57(1):183-289. doi: 10.1128/mr.57.1.183-289.1993.
2
Factor VIII, HIV and AIDS in haemophiliacs: an analysis of their relationship.血友病患者中的凝血因子VIII、艾滋病毒与艾滋病:它们之间关系的分析
Genetica. 1995;95(1-3):25-50. doi: 10.1007/BF01435000.
3
Bacterial expression of the acquired immunodeficiency syndrome retrovirus p24 gag protein and its use as a diagnostic reagent.获得性免疫缺陷综合征逆转录病毒p24 gag蛋白的细菌表达及其作为诊断试剂的用途。
Proc Natl Acad Sci U S A. 1985 Nov;82(22):7748-52. doi: 10.1073/pnas.82.22.7748.
4
Guidelines for people responsible for education and day care of children with HTLV-III/LAV infection.
CMAJ. 1986 Jul 15;135(2):134-6.
5
Transmission of human immunodeficiency virus (HIV/HTLV-III/LAV): a review.人类免疫缺陷病毒(HIV/HTLV-III/LAV)的传播:综述
Infection. 1986 Sep-Oct;14(5):203-11. doi: 10.1007/BF01644263.
6
HTLV III antibodies and immunological alterations in hemophilia patients.血友病患者中的人类嗜T淋巴细胞病毒III型抗体及免疫改变
Klin Wochenschr. 1986 Feb 3;64(3):115-24. doi: 10.1007/BF01732634.
7
Thermal inactivation of the acquired immunodeficiency syndrome virus, human T lymphotropic virus-III/lymphadenopathy-associated virus, with special reference to antihemophilic factor.获得性免疫缺陷综合征病毒(人类嗜T淋巴细胞病毒III型/淋巴结病相关病毒)的热灭活,特别涉及抗血友病因子
J Clin Invest. 1985 Aug;76(2):875-7. doi: 10.1172/JCI112045.
8
Enzyme-replacement therapy: problems and prospects.酶替代疗法:问题与前景
Pharm Weekbl Sci. 1989 Oct 20;11(5):137-45. doi: 10.1007/BF01959460.
9
Thermostability of human immunodeficiency virus (HIV-1) in a liquid matrix is far higher than that of an ecotropic murine leukemia virus.人类免疫缺陷病毒(HIV-1)在液体基质中的热稳定性远高于嗜亲性鼠白血病病毒。
Jpn J Cancer Res. 1989 Jan;80(1):1-5. doi: 10.1111/j.1349-7006.1989.tb02235.x.
10
A University of California State-supported AIDS research award program--a unique state and university partnership in AIDS research.
J Clin Immunol. 1991 Mar;11(2):65-73. doi: 10.1007/BF00917742.